The Silent Struggles of Rare Diseases: A Growing Crisis in Access to Care
“What a shame, Mr. Castillo, but there’s nothing we can do for you here,” were the words John Jairo Castillo heard seven years ago after waking up completely blind. At 20 years old, he recalls going to bed with normal vision and waking up to darkness. His story, and that of Carolina Samper, who lives with Crohn’s disease, highlight the challenges faced by individuals living with rare diseases – a growing global health concern.
Understanding the Scope of Rare Diseases
John Jairo was eventually diagnosed with Leber’s Hereditary Optic Neuropathy, a condition that falls within the 2,190 rare diseases identified in Colombia by the Ministry of Health. Globally, the World Health Organization (WHO) recognizes over 7,000 rare diseases affecting more than 300 million people worldwide. These conditions are characterized by low prevalence and are often chronic and degenerative.
These diseases, while individually rare, collectively represent a significant public health issue. The impact extends beyond the medical realm, affecting patients’ quality of life, economic productivity, and access to essential healthcare.
The Diagnostic Odyssey and the Burden of Treatment
A common thread in the experiences of those with rare diseases is the lengthy and often frustrating diagnostic process. John Jairo’s initial experience – being told nothing could be done – is sadly not uncommon. Early and accurate diagnosis is crucial, yet often delayed due to a lack of awareness and specialized expertise.
Carolina Samper’s journey with Crohn’s disease likewise illustrates this point. After initial symptoms were dismissed, she spent two years seeking a correct diagnosis and effective treatment, enduring hospital stays and ineffective therapies before finding a specialist who could properly manage her condition.
Once diagnosed, access to treatment can be another significant hurdle. John Jairo, after initially regaining some vision with idebenone, a medication sourced from the United States, has been without the drug for two and a half years due to issues with his healthcare provider, Nueva EPS. Carolina Samper faces similar challenges, currently awaiting delivery of her biological medication from the same provider for six months.
The Economic Impact and Systemic Challenges
Rare diseases often carry a substantial economic burden. More than 50% of patients require advanced therapies, like biological medications, which place a significant strain on healthcare systems. The cost of these treatments, coupled with the demand for specialized care and frequent hospitalizations, can be financially devastating for individuals and families.
The lack of timely access to medication is a critical issue. For conditions like Crohn’s disease, consistent and timely administration of biological therapies is essential to prevent the development of resistance and maintain treatment effectiveness.
The Role of Patient Advocacy and Support
Patient advocacy groups are playing an increasingly vital role in raising awareness, promoting research, and advocating for improved access to care. Carolina Samper founded the Fundación de Enfermedad Inflamatoria Intestinal (Funeiico) to support others living with Crohn’s disease in Colombia, now boasting over 500 members.
These organizations provide a platform for patients to connect, share experiences, and collectively advocate for their needs. They also work to educate healthcare professionals and policymakers about the challenges faced by the rare disease community.
Looking Ahead: Improving Access and Outcomes
Experts emphasize the need for systemic improvements to ensure that patients with rare diseases receive timely and appropriate care. This includes:
- Early Diagnosis: Increased awareness among healthcare professionals and investment in diagnostic tools.
- Access to Treatment: Streamlined processes for obtaining necessary medications and therapies.
- Specialized Care: Expanding the availability of specialists with expertise in rare diseases.
- Legal Protections: Ensuring that patients with rare diseases have priority access to healthcare services, as mandated by existing regulations.
Frequently Asked Questions
What constitutes a “rare disease”?
A rare disease is generally defined as a condition that affects a compact percentage of the population. The specific prevalence threshold varies by country, but it typically involves fewer than 1 in 2,000 people.
Why are rare diseases often difficult to diagnose?
Rare diseases are often difficult to diagnose due to a lack of awareness among healthcare professionals, the similarity of symptoms to more common conditions, and the limited availability of specialized diagnostic tests.
What is the role of patient advocacy groups?
Patient advocacy groups play a crucial role in raising awareness, promoting research, advocating for improved access to care, and providing support to individuals and families affected by rare diseases.
Is there a cure for rare diseases?
Currently, We find cures for very few rare diseases. However, ongoing research is focused on developing new treatments and therapies to improve the quality of life for those living with these conditions.
What is Leber’s Hereditary Optic Neuropathy?
It is a genetic disorder that affects the optic nerve, leading to vision loss. It is inherited through the mother’s mitochondria.
What is Crohn’s disease?
It is a type of inflammatory bowel disease that can affect any part of the gastrointestinal tract, causing chronic inflammation and a range of symptoms.
What is the current situation with sarampión (measles) in the Americas?
Mexico is currently leading in cases of sarampión in the Americas, with over 11,200 cases reported.
What can be done to prevent the spread of sarampión?
Vaccination remains the best tool for preventing and controlling the spread of sarampión.
What is the role of tecnólogos médicos (medical technologists) in diagnosing sarampión?
Medical technologists play a crucial role in confirming sarampión through specialized tests, such as serological tests that detect antibodies.
What is the impact of Nueva EPS on patient access to medication?
Patients, like John Jairo Castillo and Carolina Samper, have reported difficulties in receiving their prescribed medications through Nueva EPS.
What is the prevalence of Crohn’s disease in Colombia?
There are approximately 17 people with Crohn’s disease per 100,000 inhabitants in Colombia.
What is the role of the Ministerio de Salud (Ministry of Health) in Colombia regarding rare diseases?
The Ministry of Health has identified 2,190 rare diseases in Colombia and is working to improve access to care for those affected.
What is the significance of February 28th (or 29th in leap years) in relation to rare diseases?
February 28th (or 29th) is designated as Rare Disease Day, established in 2008 to raise awareness about the importance of medical attention, diagnosis, and treatment for these conditions.
What is the role of the Asociación Colombiana de Neurooftalmología?
The Asociación Colombiana de Neurooftalmología provides expertise and support for patients with conditions like Leber’s Hereditary Optic Neuropathy.
What is the impact of ultraprocessed foods on the development of Crohn’s disease?
Diets rich in ultraprocessed foods, processed meats, colorings, and preservatives may contribute to the development of Crohn’s disease.
What is the role of biologics in treating Crohn’s disease?
Biologics are advanced therapies used to treat Crohn’s disease, but they are expensive and require timely administration to maintain effectiveness.
What is Funeiico?
Funeiico is the Fundación de Enfermedad Inflamatoria Intestinal, a patient advocacy group founded by Carolina Samper to support individuals with Crohn’s disease in Colombia.
What is the role of the Colegio de Tecnólogos Médicos de Puerto Rico (CTMPR)?
The CTMPR ensures accurate diagnostic testing for diseases like sarampión and prepares medical technologists for increased cases.
What is the significance of the Día Mundial de las Enfermedades Raras?
It is a day to promote awareness about the importance of medical attention, diagnosis, and treatment for rare diseases.
What is the role of genetics in rare diseases?
Many rare diseases have a genetic component, such as Leber’s Hereditary Optic Neuropathy, which is inherited through the mother’s mitochondria.
What is the role of the immune system in Crohn’s disease?
In Crohn’s disease, the immune system attacks the gastrointestinal tract, causing chronic inflammation.
